Minute Media Acquires VideoVerse, Owner of Magnifi, A Leading AI Sports Video Technology Platform
September 22, 2025 21:00 ET | Source: Magnifi The acquisition comes a…
Platinum Analytics Cayman Limited Announces Closing of Its Initial Public Offering and Full Exercise of Over Allotment
Singapore, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Platinum Analytics Cayman Limited (the…
PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes
Enhanced PureTarget portfolio replaces the need for multiple tests with single scalable…
Carlsmed, Inc. Selected for Inclusion in Russell 2000 Index
September 22, 2025 09:00 ET | Source: Carlsmed CARLSBAD, Calif., Sept. 22,…
AIM ImmunoTech Announces Publication of Journal Article On the Positive Effect of Ampligen and Interferon-Alpha on Tumor Growth
OCALA, Fla., Sept. 22, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE…
CEA Industries Files Registration Statement for its $500M PIPE. CEO David Namdar Releases Letter to Shareholders
New York, Sept. 21, 2025 (GLOBE NEWSWIRE) -- CEA Industries Inc. (Nasdaq:…
ICEX and SOSA Launch Desafa San Francisco to Accelerate Spanish Startups in Silicon Valley
Credit: Maarten van den Heuvel // San Francisco, United States. MADRID, Sept.…
Tracer Launches Initial Exchange Offering on Coinstore: Building a Trusted RWA Ecosystem for Carbon Removal
Singapore, Sept. 20, 2025 (GLOBE NEWSWIRE) -- 15 September 2025 Singapore, Singapore…
Patients Taking AUSTEDO XR (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction
Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94%…
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed
Through Week 56 in the SOLARIS trial, there were no suspected or…
